Pegylated Interferon α Therapy in Chronic Delta Hepatitis: A One-Center Experience.

Hepat Mon · 2015 · PMC4385268 · PMID 25861318

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

There was a significant decrease at baseline mean ALT levels for all patients and for those receiving Peg IFN α 2a at the end of treatment and six months after the end of treatment (P < 0.05, P < 0.01, respectively), but it did not reach statistical significance in the Peg IFN α 2b group.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.